Myriad Genetics, Inc. (NASDAQ:MYGN) Q1 2023 Earnings Call Transcript May 3, 2023
Myriad Genetics, Inc. misses on earnings expectations. Reported EPS is $-0.21 EPS, expectations were $-0.19.
Matthew Scalo: Okay. Good afternoon, and welcome to the Myriad Genetics’ First Quarter 2023 Earnings Call. During the call, we will review the financial results we released today. And afterwards, we will host a question-and-answer session. Our quarterly earnings release was issued this afternoon on Form...
